Works matching DE "PHYSIOLOGICAL effects of hypoglycemic agents"

Results: 195

New-onset diabetes after liver transplantation: a national report from China Liver Transplant Registry.

Published in:

Liver International, 2016, v. 36, n. 5, p. 705, doi. 10.1111/liv.13042

By:

Ling, Qi;
Xu, Xiao;
Xie, Haiyang;
Wang, Kai;
Xiang, Penghui;
Zhuang, Runzhou;
Shen, Tian;
Wu, Jian;
Wang, Weilin;
Zheng, Shusen

Publication type:

Article

A safety update on sodium glucose co‐transporter 2 inhibitors.

Published in:

Diabetes, Obesity & Metabolism, 2019, v. 21, p. 34, doi. 10.1111/dom.13611

By:

Fitchett, David

Publication type:

Article

Comparative risk of genital infections associated with sodium‐glucose co‐transporter‐2 inhibitors.

Published in:

Diabetes, Obesity & Metabolism, 2019, v. 21, n. 2, p. 434, doi. 10.1111/dom.13531

By:

Dave, Chintan V.;
Schneeweiss, Sebastian;
Patorno, Elisabetta

Publication type:

Article

Effects on clinical outcomes of intensifying triple oral antidiabetic drug (OAD) therapy by initiating insulin versus enhancing OAD therapy in patients with type 2 diabetes: A nationwide population‐based, propensity‐score‐matched cohort study

Published in:

Diabetes, Obesity & Metabolism, 2019, v. 21, n. 2, p. 312, doi. 10.1111/dom.13525

By:

Kuo, Shihchen;
Yang, Chun‐Ting;
Wu, Jin‐Shang;
Ou, Huang‐Tz

Publication type:

Article

Safety and tolerability of dapagliflozin, saxagliptin and metformin in combination: <italic>Post‐hoc</italic> analysis of concomitant add‐on versus sequential add‐on to metformin and of triple versus dual therapy with metformin.

Published in:

Diabetes, Obesity & Metabolism, 2018, v. 20, n. 6, p. 1542, doi. 10.1111/dom.13258

By:

Del Prato, Stefano;
Rosenstock, Julio;
Garcia‐Sanchez, Ricardo;
Iqbal, Nayyar;
Chen, Hungta;
Hansen, Lars;
Johnsson, Eva;
Mathieu, Chantal

Publication type:

Article

Comparative cardiovascular safety of glucagon-like peptide-1 receptor agonists versus other antidiabetic drugs in routine care: a cohort study.

Published in:

Diabetes, Obesity & Metabolism, 2016, v. 18, n. 8, p. 755, doi. 10.1111/dom.12665

By:

Patorno, E.;
Everett, B. M.;
Goldfine, A. B.;
Glynn, R. J.;
Liu, J.;
Gopalakrishnan, C.;
Kim, S. C.

Publication type:

Article

Long-term maintenance of efficacy of dapagliflozin in patients with type 2 diabetes mellitus and cardiovascular disease.

Published in:

Diabetes, Obesity & Metabolism, 2016, v. 18, n. 8, p. 766, doi. 10.1111/dom.12666

By:

Leiter, L. A.;
Cefalu, W. T.;
Bruin, T. W. A.;
Xu, J.;
Parikh, S.;
Johnsson, E.;
Gause‐Nilsson, I.

Publication type:

Article

Efficacy and safety of combination therapy with vildagliptin and metformin versus metformin uptitration in Chinese patients with type 2 diabetes inadequately controlled with metformin monotherapy: a randomized, open-label, prospective study ( VISION).

Published in:

Diabetes, Obesity & Metabolism, 2016, v. 18, n. 8, p. 775, doi. 10.1111/dom.12667

By:

Ji, L.‐N.;
Pan, C.‐Y.;
Lu, J.‐M.;
Li, H.;
Zhu, D.‐L.;
Li, Q.;
Li, Q.‐F.;
Peng, Y.‐D.;
Tian, H.‐M.;
Yao, C.;
Zhao, Z.‐G.;
Wang, L.;
Wang, B.‐H.

Publication type:

Article

Efficacy and safety of titrated canagliflozin in patients with type 2 diabetes mellitus inadequately controlled on metformin and sitagliptin.

Published in:

Diabetes, Obesity & Metabolism, 2016, v. 18, n. 8, p. 812, doi. 10.1111/dom.12684

By:

Rodbard, H. W.;
Seufert, J.;
Aggarwal, N.;
Cao, A.;
Fung, A.;
Pfeifer, M.;
Alba, M.

Publication type:

Article

Similar efficacy and safety of once-weekly dulaglutide in patients with type 2 diabetes aged ≥65 and <65 years.

Published in:

Diabetes, Obesity & Metabolism, 2016, v. 18, n. 8, p. 820, doi. 10.1111/dom.12687

By:

Boustani, M. A.;
Pittman, I.;
Yu, M.;
Thieu, V. T.;
Varnado, O. J.;
Juneja, R.

Publication type:

Article

Efficacy and safety of sodium-glucose co-transporter-2 inhibitors in type 2 diabetes mellitus: systematic review and network meta-analysis.

Published in:

Diabetes, Obesity & Metabolism, 2016, v. 18, n. 8, p. 783, doi. 10.1111/dom.12670

By:

Zaccardi, F.;
Webb, D. R.;
Htike, Z. Z.;
Youssef, D.;
Khunti, K.;
Davies, M. J.

Publication type:

Article

Differential effects of once-weekly glucagon-like peptide-1 receptor agonist dulaglutide and metformin on pancreatic β-cell and insulin sensitivity during a standardized test meal in patients with type 2 diabetes.

Published in:

Diabetes, Obesity & Metabolism, 2016, v. 18, n. 8, p. 834, doi. 10.1111/dom.12671

By:

Mari, A.;
Del Prato, S.;
Ludvik, B.;
Milicevic, Z.;
Peña, A.;
Shurzinske, L.;
Karanikas, C. A.;
Pechtner, V.

Publication type:

Article

Effects of multiple ascending doses of the glucagon receptor antagonist PF-06291874 in patients with type 2 diabetes mellitus.

Published in:

Diabetes, Obesity & Metabolism, 2016, v. 18, n. 8, p. 795, doi. 10.1111/dom.12672

By:

Kazierad, D. J.;
Bergman, A.;
Tan, B.;
Erion, D. M.;
Somayaji, V.;
Lee, D. S.;
Rolph, T.

Publication type:

Article

Change in glycated haemoglobin levels after initiating second-line therapy in type 2 diabetes: a primary care database study.

Published in:

Diabetes, Obesity & Metabolism, 2016, v. 18, n. 8, p. 840, doi. 10.1111/dom.12673

By:

Rathmann, W.;
Bongaerts, B.;
Kostev, K.

Publication type:

Article

Efficacy and safety of teneligliptin, a novel dipeptidyl peptidase-4 inhibitor, in Korean patients with type 2 diabetes mellitus: a 24-week multicentre, randomized, double-blind, placebo-controlled phase III trial.

Published in:

Diabetes, Obesity & Metabolism, 2016, v. 18, n. 5, p. 528, doi. 10.1111/dom.12631

By:

Hong, S.;
Park, C.‐Y.;
Han, K. A.;
Chung, C. H.;
Ku, B. J.;
Jang, H. C.;
Ahn, C. W.;
Lee, M.‐K.;
Moon, M. K.;
Son, H. S.;
Lee, C. B.;
Cho, Y.‐W.;
Park, S.‐W.

Publication type:

Article

Once-weekly glucagon-like peptide-1 receptor agonist dulaglutide significantly decreases glycated haemoglobin compared with once-daily liraglutide in Japanese patients with type 2 diabetes: 52 weeks of treatment in a randomized phase III study.

Published in:

Diabetes, Obesity & Metabolism, 2016, v. 18, n. 3, p. 249, doi. 10.1111/dom.12602

By:

Odawara, M.;
Miyagawa, J.;
Iwamoto, N.;
Takita, Y.;
Imaoka, T.;
Takamura, T.

Publication type:

Article

Patient-reported outcomes among patients with type 2 diabetes mellitus treated with dapagliflozin in a triple-therapy regimen for 52 weeks.

Published in:

Diabetes, Obesity & Metabolism, 2016, v. 18, n. 3, p. 306, doi. 10.1111/dom.12604

By:

Grandy, S.;
Sternhufvud, C.;
Ryden, A.;
Sugg, J.;
Rohwedder, K.

Publication type:

Article

Use of incretin agents and risk of pancreatic cancer: a population-based cohort study.

Published in:

Diabetes, Obesity & Metabolism, 2016, v. 18, n. 3, p. 258, doi. 10.1111/dom.12605

By:

Knapen, L. M.;
van Dalem, J.;
Keulemans, Y. C.;
van Erp, N. P.;
Bazelier, M. T.;
De Bruin, M. L.;
Leufkens, H. G. M.;
Croes, S.;
Neef, C.;
de Vries, F.;
Driessen, J. H. M.

Publication type:

Article

Ten-year observational follow-up of PROactive: a randomized cardiovascular outcomes trial evaluating pioglitazone in type 2 diabetes.

Published in:

Diabetes, Obesity & Metabolism, 2016, v. 18, n. 3, p. 266, doi. 10.1111/dom.12608

By:

Erdmann, E.;
Harding, S.;
Lam, H.;
Perez, A.

Publication type:

Article

Treatment intensification with an insulin degludec ( IDeg)/insulin aspart ( IAsp) co-formulation twice daily compared with basal IDeg and prandial IAsp in type 2 diabetes: a randomized, controlled phase III trial.

Published in:

Diabetes, Obesity & Metabolism, 2016, v. 18, n. 3, p. 274, doi. 10.1111/dom.12609

By:

Rodbard, H. W.;
Cariou, B.;
Pieber, T. R.;
Endahl, L. A.;
Zacho, J.;
Cooper, J. G.

Publication type:

Article

Comparison of the pharmacokinetics and pharmacodynamics of dapagliflozin in patients with type 1 versus type 2 diabetes mellitus.

Published in:

Diabetes, Obesity & Metabolism, 2016, v. 18, n. 3, p. 236, doi. 10.1111/dom.12594

By:

Tang, W.;
Leil, T. A.;
Johnsson, E.;
Boulton, D. W.;
LaCreta, F.

Publication type:

Article

Cardiovascular and non-cardiovascular safety of dipeptidyl peptidase-4 inhibition: a meta-analysis of randomized controlled cardiovascular outcome trials.

Published in:

Diabetes, Obesity & Metabolism, 2016, v. 18, n. 3, p. 295, doi. 10.1111/dom.12595

By:

Abbas, A. S.;
Dehbi, H.‐M.;
Ray, K. K.

Publication type:

Article

Frequency of cancer events with saxagliptin in the SAVOR-TIMI 53 trial.

Published in:

Diabetes, Obesity & Metabolism, 2016, v. 18, n. 2, p. 186, doi. 10.1111/dom.12582

By:

Leiter, L. A.;
Teoh, H.;
Mosenzon, O.;
Cahn, A.;
Hirshberg, B.;
Stahre, C. A. M.;
Hoekstra, J. B. L.;
Alvarsson, M.;
Im, K.;
Scirica, B. M.;
Bhatt, D. L.;
Raz, I.

Publication type:

Article

Bioavailability of insulin detemir and human insulin at the level of peripheral interstitial fluid in humans, assessed by open-flow microperfusion.

Published in:

Diabetes, Obesity & Metabolism, 2015, v. 17, n. 12, p. 1166, doi. 10.1111/dom.12551

By:

Bodenlenz, M.;
Ellmerer, M.;
Schaupp, L.;
Jacobsen, L. V.;
Plank, J.;
Brunner, G. A.;
Wutte, A.;
Aigner, B.;
Mautner, S. I.;
Pieber, T. R.

Publication type:

Article

Comparison of basal insulin therapies with regard to the risk of acute myocardial infarction in patients with type 2 diabetes: an observational cohort study.

Published in:

Diabetes, Obesity & Metabolism, 2015, v. 17, n. 12, p. 1158, doi. 10.1111/dom.12554

By:

Kollhorst, B.;
Behr, S.;
Enders, D.;
Dippel, F.‐W.;
Theobald, K.;
Garbe, E.

Publication type:

Article

Effects of empagliflozin on blood pressure and markers of arterial stiffness and vascular resistance in patients with type 2 diabetes.

Published in:

Diabetes, Obesity & Metabolism, 2015, v. 17, n. 12, p. 1180, doi. 10.1111/dom.12572

By:

Chilton, R.;
Tikkanen, I.;
Cannon, C. P.;
Crowe, S.;
Woerle, H. J.;
Broedl, U. C.;
Johansen, O. E.

Publication type:

Article

A novel and selective sodium-glucose cotransporter-2 inhibitor, tofogliflozin, improves glycaemic control and lowers body weight in patients with type 2 diabetes mellitus.

Published in:

Diabetes, Obesity & Metabolism, 2015, v. 17, n. 10, p. 984, doi. 10.1111/dom.12538

By:

Ikeda, S.;
Takano, Y.;
Cynshi, O.;
Tanaka, R.;
Christ, A. D.;
Boerlin, V.;
Beyer, U.;
Beck, A.;
Ciorciaro, C.;
Meyer, M.;
Kadowaki, T.

Publication type:

Article

Efficacy and tolerability of saxagliptin compared with glimepiride in elderly patients with type 2 diabetes: a randomized, controlled study (GENERATION).

Published in:

Diabetes, Obesity & Metabolism, 2015, v. 17, n. 7, p. 630, doi. 10.1111/dom.12461

By:

Schernthaner, G.;
Durán‐Garcia, S.;
Hanefeld, M.;
Langslet, G.;
Niskanen, L.;
Östgren, C. J.;
Malvolti, E.;
Hardy, E.

Publication type:

Article

Safety and effectiveness of non-insulin glucose-lowering agents in the treatment of people with type 2 diabetes who observe Ramadan: a systematic review and meta-analysis.

Published in:

Diabetes, Obesity & Metabolism, 2015, v. 17, n. 7, p. 639, doi. 10.1111/dom.12462

By:

Gray, L. J.;
Dales, J.;
Brady, E. M.;
Khunti, K.;
Hanif, W.;
Davies, M. J.

Publication type:

Article

Long-term treatment with empagliflozin as add-on to oral antidiabetes therapy in Japanese patients with type 2 diabetes mellitus.

Published in:

Diabetes, Obesity & Metabolism, 2015, v. 17, n. 7, p. 665, doi. 10.1111/dom.12464

By:

Araki, E.;
Tanizawa, Y.;
Tanaka, Y.;
Taniguchi, A.;
Koiwai, K.;
Kim, G.;
Salsali, A.;
Woerle, H. J.;
Broedl, U. C.

Publication type:

Article

Incretin-based medications for type 2 diabetes: an overview of reviews.

Published in:

Diabetes, Obesity & Metabolism, 2015, v. 17, n. 7, p. 649, doi. 10.1111/dom.12465

By:

Gamble, J.‐M.;
Clarke, A.;
Myers, K. J.;
Agnew, M. D.;
Hatch, K.;
Snow, M. M.;
Davis, E. M.

Publication type:

Article

Efficacy and safety of fasiglifam ( TAK-875), a G protein-coupled receptor 40 agonist, in Japanese patients with type 2 diabetes inadequately controlled by diet and exercise: a randomized, double-blind, placebo-controlled, phase III trial.

Published in:

Diabetes, Obesity & Metabolism, 2015, v. 17, n. 7, p. 675, doi. 10.1111/dom.12467

By:

Kaku, K.;
Enya, K.;
Nakaya, R.;
Ohira, T.;
Matsuno, R.

Publication type:

Article

Faster-acting insulin aspart: earlier onset of appearance and greater early pharmacokinetic and pharmacodynamic effects than insulin aspart.

Published in:

Diabetes, Obesity & Metabolism, 2015, v. 17, n. 7, p. 682, doi. 10.1111/dom.12468

By:

Heise, T.;
Hövelmann, U.;
Brøndsted, L.;
Adrian, C. L.;
Nosek, L.;
Haahr, H.

Publication type:

Article

A systematic review of acute pancreatitis as an adverse event of type 2 diabetes drugs: from hard facts to a balanced position.

Published in:

Diabetes, Obesity & Metabolism, 2014, v. 16, n. 11, p. 1041, doi. 10.1111/dom.12297

By:

Giorda, C. B.;
Nada, E.;
Tartaglino, B.;
Marafetti, L.;
Gnavi, R.

Publication type:

Article

The amino acid response to a mixed meal in patients with type 2 diabetes: effect of sitagliptin treatment.

Published in:

Diabetes, Obesity & Metabolism, 2014, v. 16, n. 11, p. 1140, doi. 10.1111/dom.12350

By:

Muscelli, E.;
Frascerra, S.;
Casolaro, A.;
Baldi, S.;
Mari, A.;
Gall, W.;
Cobb, J.;
Ferrannini, E.

Publication type:

Article

Protamine-containing insulins are strong risk factors, and human insulin analogues are possible risk factors for insulin autoantibody: case-control study.

Published in:

2013

By:

Hiroyuki Kinoshita;
Mutsuko Yasuda;
Kaoru Nagasawa;
Fumiatsu Yakushiji

Publication type:

Case Study

Sitagliptin versus saxagliptin in decompensated type 2 diabetes mellitus patients.

Published in:

Italian Journal of Medicine, 2016, v. 10, n. 1, p. 36, doi. 10.4081/itjm.2016.558

By:

Asti, Antonio;
D'Alessandro, Alessandra;
Zito, Francesco Paolo;
Nardi, Salvatore;
Sarnelli, Giovanni;
Maresca, Giorgio;
D'Alessandro, Giuseppe

Publication type:

Article

Metformin Treatment Decreases mTOR mRNA Level in MCF-7 Breast Cancer Cells.

Published in:

Ibnosina Journal of Medicine & Biomedical Sciences, 2016, v. 8, n. 4, p. 99, doi. 10.4103/1947-489X.210230

By:

Alalem, Mohamed;
Ray, Alpana;
Ray, Bimal K.

Publication type:

Article

Effects of Glucagon-Like Peptide-1 Receptor Agonists on Weight Loss in Patients with Type 2 Diabetes: A Systematic Review and Network Meta-Analysis.

Published in:

Journal of Diabetes Research, 2015, v. 2015, p. 1, doi. 10.1155/2015/157201

By:

Sun, Feng;
Chai, Sanbao;
Li, Lishi;
Yu, Kai;
Yang, Zhirong;
Wu, Shanshan;
Zhang, Yuan;
Ji, Linong;
Zhan, Siyan

Publication type:

Article

A randomized controlled clinical trial of vildagliptin plus metformin combination therapy in patients with type II diabetes mellitus.

Published in:

Experimental & Therapeutic Medicine, 2014, v. 7, n. 4, p. 799, doi. 10.3892/etm.2014.1545

By:

YONG SU;
YA-LI SU;
LI-FANG LV;
LI-MIN WANG;
QUAN-ZHONG LI;
ZHI-GANG ZHAO

Publication type:

Article

Efficacy of alogliptin in preventing non-alcoholic fatty liver disease progression in patients with type 2 diabetes.

Published in:

Biomedical Reports, 2016, v. 4, n. 2, p. 183, doi. 10.3892/br.2016.569

By:

TSUYOSHI MASHITANI;
RYUICHI NOGUCHI;
YASUSHI OKURA;
TADASHI NAMISAKI;
AKIRA MITORO;
HITOSHI ISHII;
TOSHIYA NAKATANI;
EIRYO KIKUCHI;
HIROTO MORIYASU;
MASAMI MATSUMOTO;
SHINYA SATO;
TATSUICHI AN;
HIROSHI MORITA;
SIGEYUKI AIZAWA;
YASUNORI TOKUOKA;
MASATOSHI ISHIKAWA;
YOSHINOBU MATSUMURA;
HIROMASA OHIRA;
ATSUKO KOGURE;
KAZUHIRO NOGUCHI

Publication type:

Article

Remission of hyperglycemia after withdrawal of oral antidiabetic drugs in Japanese patients with early‐stage type 2 diabetes.

Published in:

Journal of Diabetes Investigation, 2018, v. 9, n. 5, p. 1119, doi. 10.1111/jdi.12813

By:

Hirukawa, Hidenori;
Hashiramoto, Mitsuru;
Tanizawa, Yukio;
Kaku, Kohei;
Pioglitazone And Sulfonylurea Remission From Type 2 Diabetes Mellitus And Anti‐atherosclerosis In Japan (prevent‐j) Study Group

Publication type:

Article

Liraglutide is effective and well tolerated in combination with an oral antidiabetic drug in Japanese patients with type 2 diabetes: A randomized, 52-week, open-label, parallelgroup trial.

Published in:

Journal of Diabetes Investigation, 2016, v. 7, n. 1, p. 76, doi. 10.1111/jdi.12367

By:

Kaku, Kohei;
Kiyosue, Arihiro;
Ono, Yuri;
Shiraiwa, Toshihiko;
Kaneko, Shizuka;
Nishijima, Keiji;
Bosch‐Traberg, Heidrun;
Seino, Yutaka

Publication type:

Article

Effect and cardiovascular safety of adding rosiglitazone to insulin therapy in type 2 diabetes: A meta-analysis.

Published in:

Journal of Diabetes Investigation, 2015, v. 6, n. 1, p. 78, doi. 10.1111/jdi.12246

By:

Lu, Yu;
Ma, Delin;
Xu, Weijie;
Shao, Shiying;
Yu, Xuefeng

Publication type:

Article

The curious case of postprandial glucose less than fasting glucose: little things that matter much.

Published in:

Clinical Chemistry & Laboratory Medicine, 2018, v. 56, n. 9, p. e223, doi. 10.1515/cclm-2017-0984

By:

Bora, Kaustubh;
Barman, Bhupen;
Ayubi, Abdul Wahid

Publication type:

Article

Cardiovascular Safety of New Drugs for Diabetes: Getting the Balance Right?

Published in:

Pharmaceutical Medicine, 2014, v. 28, n. 3, p. 109, doi. 10.1007/s40290-014-0053-7

By:

Krentz, Andrew;
Hompesch, Marcus

Publication type:

Article

Seguridad y efectividad de los hipoglucemiantes orales en mujeres con diabetes gestacional. Revisión de la bibliografía.

Published in:

Ginecología y Obstetricia de México, 2014, v. 82, n. 7, p. 454

By:

Buitrago-Leal, Marcela;
Molina-Giraldo, Saulo

Publication type:

Article

Hypoglycemic effects of an aqueous extract of Bauhinia forficata on the salivary glands of diabetic mice.

Published in:

Pakistan Journal of Pharmaceutical Sciences, 2012, v. 25, n. 3, p. 493

By:

Curcio, Sergio Augusto Fudaba;
Stefan, Luciana Francine Bocchi;
Randi, Bruno Azevedo;
Dias, Marco Antonio;
Silva, Rodrigo Eduardo da;
Caldeira, Eduardo José

Publication type:

Article

Oxidative/Nitrosative Stress and Protein Damages in Aqueous Humor of Hyperglycemic Rabbits: Effects of Two Oral Antidiabetics, Pioglitazone and Repaglinide.

Published in:

Experimental Diabetes Research, 2012, p. 1, doi. 10.1155/2012/653678

By:

Gumieniczek, Anna;
Owczarek, Beata;
Pawlikowska, Bernadeta

Publication type:

Article

Probing the mechanism of the anti-diabetic potential of a terpenoid from Elephantopus scaber L., an Indian ethnomedicinal plant in STZ diabetic rats- In vivo and in silico analysis.

Published in:

Indian Journal of Biochemistry & Biophysics, 2018, v. 55, n. 6, p. 384

By:

R., Jasmine;
A., Ganesh Kumar;
R., Rajaram

Publication type:

Article